I'm well aware of that. This clearance is for the insulin dose adjustment feature to the original device that they applied for last December with the FDA.
In my opinion this addition is what sets ALR's monitoring system apart from the competition's.
And watch this stock stair step higher as they announce details of sponsorship, product launches, SEC compliance, etc...
Lots of upside here in my opinion, with less risks than most stinky pinkies. This FDA clearance is a game changer for ALR.
Market Data 
Markets 
AI
